Responses
Clinical and epidemiological research
Extended report
Clinical efficacy of leflunomide in primary Sjögren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression
Compose a Response to This Article
Other responses
No responses have been published for this article.